http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S60199822-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5929f2d6f4dba84be8dd3a8ba633db12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22 |
| filingDate | 1984-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44444f1a3eacf8ed69cc3a346cae7511 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_212894ad5d5625618fd09ada9b8c1691 |
| publicationDate | 1985-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-S60199822-A |
| titleOfInvention | External pharmaceutical for percutaneous absorption |
| abstract | PURPOSE: The titled pharmaceutical, obtained by incoporating a polypeptide having physiological activity such as central activating action or hormonal action, with a specific higher aliphatic compound as an absorption promoter, and capable of enhancing the percutaneous absorption of polypeptides and prolonging the drug effect without side effects. n CONSTITUTION: An external pharmaceutical for percutaneous absorption obtained by incorporating a polypeptide having physiological activity, e.g. luteinzing hormone, thyrotropin-releasing hormone or vasopressin, with at least one selected from the group consisting of 5W30C aliphatic monocarboxylic acids, 10W22C monohydric alcohols, 7W17C aliphatic monoamides and 10W16C aliphatic monoamines. The higher aliphatic compound enhances the percutaneous absorption of the polypeptide based drug. Low-molecular weight polypeptide based drugs having poor absorbability through digestive tracts can be percutaneously adnimistered without using injection nor oral administration, and the drug effect can be maintained for a long period without pain nor side effect. n COPYRIGHT: (C)1985,JPO&Japio |
| priorityDate | 1984-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 44.